Meanwhile, we further found that increased KL-6 level might be an immunological biomarker to distinguish the progressive ILD, particularly in IIM-ILD and indium exposure ILD (11, 29, 36, 38). This evidence concerns the gene MUC1 and interstitial lung disease.